Core A. Two Projects and one Core within this POI program receive support by the now well-established Core A. Indeed, the Program requires an effective Administrative Core component as a central element of fiscal and scientific coordination. With this, the four goals of Core A are as follows: 1) To coordinate the budgetary and fiscal aspects of the POI. The proposed Program involves direct cost disbursements to investigators of Projects 1 and 2, as well as Cores A and B;hence careful oversight represents an absolute administrative requirement. 2) To facilitate communication among investigators within the Program. This takes form through performance of a variety of functions ranging from regularly scheduled meetings between Program investigators to training of Project investigators by Program Cores. 3) To coordinate the goals and activities of the POI as a Program Executive Committee and respond to input provided by Extemal Advisors;individuals that provide on-site visits to the University of Florida as well as teleconferance based reviews;both for the purpose of maximizing the progress and success of the Program. 4) To organize the collection of human materials, generate appropriate data sets, provide statistical support to the Program, assure compliance with appropriate regulatory bodies and edicts (e.g., Instituional Review Board, Institutional Animal Care and Use Committee, Health Insurance Portability and Accountability Act, etc.) and facilitate communication of Program results. In addition to the aforementioned functions, the administrative staff of the Program will also be responsible for communication with the NIH staff, as well as for assistance with publications and presentation of Program results. The successful completion of these POI studies should continue to prove beneficial for improving our understanding of those events critical to the pathogenesis and natural history of TID, identifying markers that enhance our ability to monitor immune activities in the disease, and developing immunotherapies capable of preventing or reversing the disorder.

Public Health Relevance

Patients with TID, as well as those at risk for developing the disorder, stand to benefit from the research overseen by the Administrative Core A. This, through the Program's ability to provide knowledge leading to a better understanding of why the disease develops and ultimately, as well as the identification of a means to prevent and/or cure this disease.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-PA-I)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Florida
United States
Zip Code
Creusot, Remi J; Giannoukakis, Nick; Trucco, Massimo et al. (2014) It's time to bring dendritic cell therapy to type 1 diabetes. Diabetes 63:20-30
Zheng, Shuyao; Mathews, Clayton E (2014) Metabolic abnormalities in the pathogenesis of type 1 diabetes. Curr Diab Rep 14:519
Atkinson, Mark A (2014) Losing a grip on the notion of ?-cell specificity for immune responses in type 1 diabetes: can we handle the truth? Diabetes 63:3572-4
Chen, Jing; Mathews, Clayton E (2014) Use of chemical probes to detect mitochondrial ROS by flow cytometry and spectrofluorometry. Methods Enzymol 542:223-41
Lantow, Margareta; Sivakumar, Ramya; Zeumer, Leilani et al. (2013) The granulocyte colony stimulating factor pathway regulates autoantibody production in a murine induced model of systemic lupus erythematosus. Arthritis Res Ther 15:R49
Myhr, Courtney B; Hulme, Maigan A; Wasserfall, Clive H et al. (2013) The autoimmune disease-associated SNP rs917997 of IL18RAP controls IFNýý production by PBMC. J Autoimmun 44:8-12
Hulme, Maigan A; Wasserfall, Clive H; Atkinson, Mark A et al. (2012) Central role for interleukin-2 in type 1 diabetes. Diabetes 61:14-22
Brusko, Todd M; Wasserfall, Clive H; Hulme, Maigan A et al. (2009) Influence of membrane CD25 stability on T lymphocyte activity: implications for immunoregulation. PLoS One 4:e7980
Matangkasombut, Ponpan; Marigowda, Gautham; Ervine, Aaron et al. (2009) Natural killer T cells in the lungs of patients with asthma. J Allergy Clin Immunol 123:1181-5
Atkinson, Mark A; Gianani, Roberto (2009) The pancreas in human type 1 diabetes: providing new answers to age-old questions. Curr Opin Endocrinol Diabetes Obes 16:279-85

Showing the most recent 10 out of 63 publications